Business UpdateJul 6, 2026, 08:01 AM
Belite Bio to Participate in Piper Sandler Investor Symposium
AI Summary
Belite Bio, Inc. announced its participation in a fireside chat at the Piper Sandler Virtual Ophthalmology Investor Symposium. The event is scheduled for July 9, 2026, at 12:30 pm ET, and a webcast will be available on the company's investor relations website. Belite Bio is a clinical-stage drug development company focused on degenerative retinal diseases, with its lead candidate tinlarebant in Phase 2/3 and Phase 3 trials.
Key Highlights
- Belite Bio will participate in a fireside chat at the Piper Sandler Virtual Ophthalmology Investor Symposium.
- The event is scheduled for Thursday, July 9, 2026, at 12:30 pm ET.
- A webcast of the presentation will be available on the company's investor relations website.
- The replay will be archived for 90 days following the presentation date.
Price Impact
More from BLTE